Antiphospholipid Syndrome in Systemic Autoimmune Diseases: Volume 12
2. Auflage
Erschienen am 29. Juni 2016
Buch
Hardcover
326 Seiten
978-0-444-63655-3 (ISBN)
Beschreibung
Antiphospholipid Syndrome in Systemic Autoimmune Diseases, Second Edition provides an overview of our current understanding of this major disease. It includes the latest information on the new pathogenetic mechanisms involved, along with clinical manifestations in both the thrombotic and non-thrombotic manifestations of this important disease.
Antiphospholipid syndrome is an autoimmune disease that causes abnormal blood clots. It is now recognized as a major cause of common conditions, including stroke, heart attack, miscarriage, epilepsy, and memory loss, and as such is gaining recognition in all branches of medicine, from obstetrics to cardiology, and from psychiatry to orthopedics.
Antiphospholipid syndrome is an autoimmune disease that causes abnormal blood clots. It is now recognized as a major cause of common conditions, including stroke, heart attack, miscarriage, epilepsy, and memory loss, and as such is gaining recognition in all branches of medicine, from obstetrics to cardiology, and from psychiatry to orthopedics.
Weitere Details
Reihe
Auflage
2nd edition
Sprache
Englisch
Verlagsort
Oxford
Großbritannien
Verlagsgruppe
Elsevier Science & Technology
Zielgruppe
Für Beruf und Forschung
Produkt-Hinweis
laminiert
Maße
Höhe: 234 mm
Breite: 156 mm
Dicke: 19 mm
Gewicht
637 gr
ISBN-13
978-0-444-63655-3 (9780444636553)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Klassifikation
Weitere Ausgaben
Andere Ausgaben
R. Cervera | Joan Carles Reverter | Frcp Khamashta MD
Antiphospholipid Syndrome in Systemic Autoimmune Diseases
E-Book
06/2016
2. Auflage
Elsevier
130,00 €
Als Download verfügbar
Vorauflage
R. Cervera | Joan Carles Reverter | Munther Khamashta
Antiphospholipid Syndrome in Systemic Autoimmune Diseases: Volume 12
Buch
04/2009
Elsevier
209,88 €
Artikel ist vergriffen; siehe Neuauflage
Personen
Munther Khamashta is Professor/Consultant Physician and Director of The Graham Hughes Lupus Research Laboratory at St Thomas' Hospital, London, and runs a large lupus pregnancy clinic. He studied medicine in Barcelona and internal medicine in Madrid, Spain, where he developed an interest in connective tissue diseases and received his PhD. He was awarded the MRCP in 1999 and FRCP in 2002. He joined the Lupus Unit in London 25 years ago and has been instrumental in developing it into an internationally recognised tertiary centre receiving referrals from all over the UK, see https://kclpure.kcl.ac.uk/portal/en/persons/munther-khamashta(e30b3284-8df1-4cc2-9856-9bca61db843e)/biography.html Gerard Espinosa, MD, PhD is Consultant at the Department of Autoimmune Diseases, Hospital Clinic, Barcelona, member of the Research Team on Systemic Autoimmune Diseases (coordinator of the Clinical Trials Unit) at the Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona and Associate Professor at the Department of Medicine, Universitat de Barcelona, Barcelona, Catalonia, Spain.
Herausgeber*in
Department of Autoimmune Diseases, Hospital Clinic, Barcelona, Spain
Servei d'Hemoterapia i Hemostasia, Hospital Clinic, Barcelona, Spain
Professor/Consultant Physician and Director of The Graham Hughes Lupus Research Laboratory at St Thomas' Hospital, London, and runs a large lupus pregnancy clinic.
Department of Autoimmune Diseases, Hospital Clinic, Barcelona, Catalonia, Spain
Inhalt
1. History, Classification, and Subsets of the Antiphospholipid Syndrome2. Epidemiology of the Antiphospholipid Syndrome3. Mechanisms of Action of the Antiphospholipid Antibodies4. Laboratory Markers With Clinical Significance in the Antiphospholipid Syndrome5. Genetic and Epigenetic Aspects of Antiphospholipid Syndrome: What we knew, what we know6. Thrombotic Manifestations of the Antiphospholipid Syndrome7. Obstetric Manifestations of the Antiphospholipid Syndrome8. Thrombocytopenia in the Antiphospholipid Syndrome9. Nonclassification Criteria Manifestations of the Antiphospholipid Syndrome10. Paediatric Antiphospholipid Syndrome11. Antiphospholipid Antibodies and Their Relationship With Infections, Vaccines, and Drugs12. Antiphospholipid Syndrome Associated With Malignancies13. Antiphospholipid Antibodies and Atherosclerosis14. Global Antiphospholipid Syndrome Score15. Primary Prophylaxis in Patients With Positive Antiphospholipid Antibodies16. Treatment of Thrombosis in Antiphospholipid Syndrome17. Treatment of Catastrophic Antiphospholipid Syndrome18. Treatment of Pregnancy Complications in Antiphospholipid Syndrome19. Prognosis in Antiphospholipid Syndrome